Martin M. Fabani

Martin M. Fabani

Auto-generated profile, based on publicly available information

Martin M. Fabani

Medical Research Council, Laboratory of Molecular Biology, Cambridge CB2 0QH, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2010 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MFMartin M. Fabani
Martin M. Fabani
CACei Abreu-Goodger
Cei Abreu-Goodger
DWDonna Williams
Donna Williams
PLPaul A. Lyons
Paul A. Lyons
ATAdrian Gabriel Torres
Adrian Gabriel Torres
EVElena Vigorito
Elena Vigorito
MicroRNAs (miRNAs) play an important role in diverse physiological processes and are potential therapeutic agents. Synthetic oligonucleotides (ONs) of different chemistries have proven successful for blocking miRNA expression. However, their specificity and efficiency have not been fully evaluated. Here, we show that peptide nucleic acids (PNAs) efficiently block a key inducible miRNA expressed in the haematopoietic system, miR-155, in cultured B cells as well as in mice. Remarkably, miR-155 inhibition by PNA in primary B cells was achieved in the absence of any transfection agent. In mice, the high efficiency of the treatment was demonstrated by a strong overlap in global gene expression between B cells isolated from anti-miR-155 PNA-treated and miR-155-deficient mice. Interestingly, PNA also induced additional changes in gene expression. Our analysis provides a useful platform to aid the design of efficient and specific anti-miRNA ONs for in vivo use.

1 September 2008 in Nucleic Acids Symposium Series
Verified
Journal Article
Open access
PDF file
GIGabriela D. Ivanova
Gabriela D. Ivanova
MFMartin M. Fabani
Martin M. Fabani
AAAndrey A. Arzumanov
Andrey A. Arzumanov
RARachida Abes
Rachida Abes
HYHaifang Yin
Haifang Yin
MGMichael J Gait
Michael J Gait
Serum-stabilized PNA-internalization peptides (Pip) conjugated to PNA complementary to the 705 aberrant β-globin splice site are able to correct splicing and increase luciferase production in Hela pLuc705 cells with sub μM EC50 in the absence of a transfection agent. Inhibition of microRNA-122 in liver cells is achieved by treatment with complementary PNA containing just a few attached Lys residues, again without need of a transfection agent.